Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome1
To access this article, please choose from the options below
1 Supported in part by a grant (CA 33050) from the National Institutes of Health, the Charles A. Dana Foundation, the Zelda Weintraub Cancer Foundation, the Robert J. Kleberg and Helen C. Kleberg Foundation, the Vincent Astor Foundation, and the Frito-Lay/New York Yankees Challenge Fund.
PII: S0022-3476(05)83041-0
© 1991 Published by Elsevier Inc.
